Roles and Responsibilities
- Serve as the Company’s trusted face to the clinical practice, providing clinical support while advancing research data collection.
- Interface directly with the healthcare providers and patients.
- Perform peer review of clinical documentation for data quality and completeness.
- Partner with Senior DHS to address any clinic or team issues and concerns.
- Obtain informed consent for N-Power Medicine’s clinical trials.
- Assist and participate in the site clinical trial initiation and clinical trial(s) activities as assigned.
- Ensure adherence to study protocols, data completeness and patient consent.
- Assist in patient recruitment strategies where appropriate.
- Foster collaborative relationships by effectively communicating with clinical site staff, internal stakeholders, and the N-Power Medicine team by attending site specific meetings.
- Build and maintain relationships at the clinical site, becoming part of the functional team of practitioners.
- Ensure quality and integrity of data capture, compliance and confidentiality with N-Power Medicine’s and site’s policies, standard operating procedures (SOPs), and Good Clinical Practice (GCP).
- Respond to queries regarding missing, aberrant, or potential outlier data and data verification- escalate to the health care provider as necessary for resolution.
- Provide proactive input and user experiences for our software.
- Additional duties and responsibilities as required.
- Generous, curious and humble.
Qualifications
- 3+ years of experience in oncology clinical research and/or oncology ambulatory care preferred
- Bachelor’s degree, focused in health science or related field preferred
- Certified Clinical Research Coordinator, Associate or Professional (CCRC, CCRA or CCRP) preferred
- Knowledge of clinical trials, study-specific operating procedures and patient consent forms
- Strong desire to drive a paradigm change in clinical research conduct and improve patients’ lives
- Compassionate focused patient care
- Supports and encourages other team members, contributing to a positive team environment
- Self-starter, able to work independently, prioritize actively, seek input, and problem solve in complex and fast-evolving environments
- Results oriented focused on delivering the goals set-forth
- Attention to detail and strong organizational skills
- Excellent oral/written communication and interpersonal skills
- Critical thinking and proven problem-solving skills
- Work hours are dependent on local Network Partner Clinics (typically M-F, 8-5pm)
Travel Requirements
- Daily travel between sites may be required
Skills Required
- Knowledge of clinical trials, study-specific operating procedures and patient consent forms
- Experience obtaining informed consent and ensuring adherence to study protocols, GCP and SOPs
- Excellent oral/written communication and interpersonal skills
- Self-starter, able to work independently, prioritize, and problem solve in fast-evolving environments
- Attention to detail and strong organizational skills
- Currently authorized to work in the U.S.; employer will not sponsor work visas
- 3+ years of experience in oncology clinical research and/or oncology ambulatory care
- Bachelor's degree in health science or related field
- Certified Clinical Research Coordinator, Associate or Professional (CCRC, CCRA or CCRP)
What We Do
N-Power Medicine is developing a radically faster, smarter paradigm for drug development that enables biopharma to move beyond traditional randomized clinical trials. Through a network of community oncology practices and proprietary infrastructure, N-Power has built a next-generation platform where every cancer patient can participate in research, either as a trial participant or as part of a regulatory-grade Prospective External Control Arm (ProECA). Powered by the Kaleido™ Registry and ProECA platform, N-Power’s model reduces reliance on randomization, cuts years off development timelines, and saves hundreds of millions of dollars per program. N-Power is expanding access to clinical trials and redefining what’s possible in cancer drug development.






